The 36-month beta value for SVRA is also noteworthy at 0.67. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 3 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The public float for SVRA is 88.75M, and at present, short sellers hold a 14.56% of that float. The average trading volume of SVRA on December 26, 2024 was 1.45M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
SVRA) stock’s latest price update
Savara Inc (NASDAQ: SVRA) has seen a decline in its stock price by -1.54 in relation to its previous close of 3.25. However, the company has experienced a -0.62% decline in its stock price over the last five trading sessions. businesswire.com reported 2024-12-23 that LANGHORNE, Pa.–(BUSINESS WIRE)–Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to five new employees. On December 20, 2024, the Compensation Committee of Savara’s Board of Directors granted the inducement awards to five new employees who recently joined the Company. The inducement awards consist of options to purchase an aggregate of 100,000 shares of the Company’s common stock and rest.
SVRA’s Market Performance
Savara Inc (SVRA) has experienced a -0.62% fall in stock performance for the past week, with a -4.76% drop in the past month, and a -22.89% drop in the past quarter. The volatility ratio for the week is 6.92%, and the volatility levels for the past 30 days are at 6.30% for SVRA. The simple moving average for the last 20 days is -4.81% for SVRA stock, with a simple moving average of -23.48% for the last 200 days.
Analysts’ Opinion of SVRA
Many brokerage firms have already submitted their reports for SVRA stocks, with Wells Fargo repeating the rating for SVRA by listing it as a “Overweight.” The predicted price for SVRA in the upcoming period, according to Wells Fargo is $8 based on the research report published on December 20, 2024 of the current year 2024.
Evercore ISI, on the other hand, stated in their research note that they expect to see SVRA reach a price target of $5, previously predicting the price at $7. The rating they have provided for SVRA stocks is “In-line” according to the report published on November 13th, 2024.
JMP Securities gave a rating of “Mkt Outperform” to SVRA, setting the target price at $8 in the report published on February 15th of the current year.
SVRA Trading at -7.44% from the 50-Day Moving Average
After a stumble in the market that brought SVRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -43.86% of loss for the given period.
Volatility was left at 6.30%, however, over the last 30 days, the volatility rate increased by 6.92%, as shares sank -6.16% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.57% lower at present.
During the last 5 trading sessions, SVRA fell by -0.62%, which changed the moving average for the period of 200-days by -34.83% in comparison to the 20-day moving average, which settled at $3.36. In addition, Savara Inc saw -31.91% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SVRA starting from Lowrance David L, who sale 25,000 shares at the price of $3.33 back on Dec 16 ’24. After this action, Lowrance David L now owns 381,005 shares of Savara Inc, valued at $83,278 using the latest closing price.
Pauls Matthew, the CHIEF EXECUTIVE OFFICER of Savara Inc, sale 54,702 shares at $3.31 during a trade that took place back on Dec 16 ’24, which means that Pauls Matthew is holding 1,536,379 shares at $180,828 based on the most recent closing price.
Stock Fundamentals for SVRA
The total capital return value is set at -0.4. Equity return is now at value -47.95, with -39.41 for asset returns.
Based on Savara Inc (SVRA), the company’s capital structure generated 0.12 points at debt to capital in total, while cash flow to debt ratio is standing at -3.07.
Currently, EBITDA for the company is -59.13 million with net debt to EBITDA at -0.06. The liquidity ratio also appears to be rather interesting for investors as it stands at 17.70.
Conclusion
In summary, Savara Inc (SVRA) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
